A Phase III, Double-Blind. Placebo-Controlled, Multicenter, Randomized Study of Pracinostat in Combination with Azacitidine in Patients > 18 Years with Newly Diagnosed Acute Myeloid Leukemia unfit for Standard Induction Chemotherapy.

  • Wei, Andrew (Primary Chief Investigator (PCI))
  • Kennedy, Nola (Project Manager)

Project: Research

StatusActive
Effective start/end date4/03/1931/10/23